The global protein expression market was valued at USD 3.16 Billion in 2025. It is poised to grow at a CAGR of 5.40% during the forecast period of 2026-2035, and reach USD 5.35 Billion by 2035. The market growth is driven by the rising demand for biologics, increasing prevalence of chronic diseases, and transformative technological advancements in expression systems.
Other key players in the market are QIAGEN N.V., Lonza Group AG, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, New England Biolabs, Oxford Expression Technologies Ltd. (OET), Synthetic Genomics, Inc., Biomatik Corporation, Cayman Chemical Company, Zymo Research Corporation.
Latest News on the Protein Expression Market (2026)
April 2026: MIT Researchers Bring AI-Driven Protein Design Tools Mainstream
As reported by MIT News, researchers launched OpenProtein.AI, an open platform that brings advanced AI-driven protein design tools to a broader scientific community. The tools accelerate engineering of novel enzymes, antibodies, and therapeutic proteins, supporting strong upstream demand for cell-free expression systems, mammalian and microbial production platforms, and high-throughput screening reagents across biopharmaceutical and academic research markets.March 2026: Cell-Free Protein Expression Systems Gain Strong Bioprocessing Adoption Momentum
According to research summarized by the U.S. National Institutes of Health, cell-free protein expression continues to gain traction as a flexible alternative to traditional cell-based biomanufacturing for complex, toxic, and post-translationally modified proteins. Strategic partnerships and licensing agreements are intensifying among reagent suppliers and biopharmaceutical developers, supporting accelerating revenue growth across cell-free expression kits, lysates, and on-demand protein production platforms.Key Market Trends and Insights
- By type of expression, mammalian expression systems held approximately 37% share in the historical period.
- Based on the product type, reagents led the segment with nearly 44% market share in the historical period.
- By application, therapeutic proteins accounted for around 43% share in the historical period.
Market Size and Forecast
- Market Size (2025): USD 3.16 Billion
- Projected Market Size (2035): USD 5.35 Billion
- CAGR (2026-2035): 5.40%
Protein Expression Market Overview
Protein expression is the biological and biotechnological process by which genetic information from DNA is converted into functional proteins. In a natural context, it is a key component of gene expression, encompassing transcription of DNA into messenger RNA (mRNA), subsequent translation into amino acids, and finally folding into a functional 3D structure. The market is fueled by the pharmaceutical industry’s aggressive shift toward biologics and precision medicine. The market was valued at USD 3.16 Billion in 2025. The growth is further supported by the surge in high-value drug development.Protein Expression Market Growth Drivers
Rising Integration of AI-Driven Protein Analytics to Enhance the Market Value
The increasing integration of artificial intelligence in protein analysis is significantly driving market growth by improving the accuracy and efficiency of protein expression studies. In July 2025, researchers from Poznan University of Medical Sciences and the University of São Paulo developed PROTsi, an AI-based model that analyzes protein expression to predict tumor aggressiveness and identify therapeutic targets. This advancement supports biomarker-based treatment, patient stratification, and drug response prediction, thereby strengthening the role of protein expression technologies and accelerating overall market growth.Protein Expression Market Trends
Some notable trends in the market include the expanding adoption of cell-free protein expression technologies.Growing Expansion of Cell-Free Protein Expression Technologies is Likely to Accelerate Market Growth
The market is witnessing a growing shift toward advanced cell-free protein expression platforms that enable rapid and efficient synthesis of complex proteins. In April 2025, LenioBio partnered with Avantor to expand the accessibility of its ALiCE® technology across Europe, enhancing research capabilities and reducing dependency on traditional cell-based systems. This trend is expected to streamline protein production workflows and significantly support overall market growth.Protein Expression Market Segmentation
Market Breakup by Type of Expression System
- Bacterial Expression Systems
- Mammalian Expression Systems
- Yeast Expression Systems
- Insect Expression Systems
- Cell-Free Expression Systems
- Algal Expression Systems
- Other Expression Systems
Market Breakup by Product Type
- Reagents
- Expression Vectors
- Competent Cells
- Instruments
- Services
Market Breakup by Application
- Therapeutic Proteins
- Research Applications
- Industrial Proteins
- Diagnostic Proteins
- Others
Market Breakup by Technique
- Ion Exchange Chromatography
- Hydrophobic Interaction Chromatography (HIC)
- Affinity Chromatography
- Size Exclusion Chromatography
- Others
Market Breakup by Cell Type
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
- Insect Cells
- Algal Cells
- Cell-Free Systems
Market Breakup by End User
- Biotechnology and Pharmaceutical Companies
- Academic Research Institutes
- Contract Research Organizations (CROs)
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Protein Expression Market Share
Mammalian Expression Systems to Dominate Market Segmentation by Type
The mammalian expression systems are likely to hold a significant share in the market Among all the types by offering an unrivaled capacity for complex post-translational modifications (PTMs). This segment holds capacity, such as glycosylation and proper folding, which are critical for the biological activity and safety of modern therapeutics. As financial risk-aversion drives investment toward established, regulatory-proven technologies like CHO cells, the sector continues to grow despite higher operational costs, offering a lower "certainty premium" over faster but less complex alternatives.Protein Expression Market Analysis by Region
The regions included in the market are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America continues anticipated to hold a substantial market share. This supremacy is driven by robust biopharmaceutical infrastructure and substantial R&D investments from organizations like the NIH. From a macroeconomic perspective, the region's concentration of liquid capital and high-tier academic centers creates a fertile environment for innovation, even amidst fluctuating interest rates. Recently, the FDA's expedited approval timelines and a surge in mammalian-based biologic production have further solidified this leadership. This growth trajectory is sustained by relentless technological advancements, such as AI-driven protein design platforms.Leading Players in the Protein Expression Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. is the dominant leader in the market due to its high-growth segments like cell-free protein expression. The company provides a vertically integrated ecosystem that spans from early-stage gene synthesis and cloning to large-scale commercial manufacturing through its specialized brands like Invitrogen, Gibco, and Patheon.Merck KGaA (Sigma-Aldrich Corporation)
Merck KGaA (Sigma-Aldrich Corporation) is a primary leader in the market, ranked as a top-tier provider. The company’s Life Science business sector, provides a comprehensive end-to-end ecosystem for protein research, from gene cloning to industrial-scale bioprocessing.Agilent Technologies, Inc.
Agilent Technologies, Inc. is a major global player in the protein expression market, positioning itself as a leader in high-performance analytical tools, reagents, and end-to-end biopharma solutions. Unlike competitors who focus heavily on high-volume media, Agilent’s market strength lies in solving complex expression challenges, such as protein insolubility and codon bias, through specialized host cells and advanced characterization instruments.Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is a vital "enabler" in the market, specializing in the specialized instrumentation and reagents essential for the separation, purification, and analysis of expressed proteins. The company is the industry standard for the downstream workflow, particularly in electrophoresis and chromatography.Other key players in the market are QIAGEN N.V., Lonza Group AG, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, New England Biolabs, Oxford Expression Technologies Ltd. (OET), Synthetic Genomics, Inc., Biomatik Corporation, Cayman Chemical Company, Zymo Research Corporation.
Key Questions Answered in the Protein Expression Market Report
- What was the protein expression market value in 2025?
- What is the protein expression market forecast outlook for 2026-2035?
- What major factors aid the demand for the protein expression market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major protein expression market trends?
- Which type of expression system is expected to dominate the market segment?
- Which product type is projected to lead the market segment?
- Which application is anticipated to drive the market segment?
- Which technique is likely to dominate the market segment?
- Which cell type is likely to dominate the market segment?
- Which end-user is likely to dominate the market segment?
- Which region is likely to dominate the market segment?
- Who are the key players in the protein expression market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
1 Preface
3 Global Protein Expression Market Overview
4 Global Protein Expression Market Landscape*
5 Global Protein Expression Market Dynamics
6 Global Protein Expression Market Segmentation (219-2035)
7 North America Protein Expression Market (219-2035)
8 Europe Protein Expression Market (219-2035)
9 Asia Pacific Protein Expression Market (219-2035)
10 Latin America Protein Expression Market (219-2035)
11 Middle East and Africa Protein Expression Market (219-2035)
12 Regulatory Framework
13 Patent Analysis
14 Grants Analysis
15 Funding and Investment Analysis
16 Partnership and Collaborations Analysis
17 Supplier Landscape
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Merck KGaA (Sigma-Aldrich Corporation)
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
